HPR158 Progression Free Survival and Duration of Treatment as a Proxy of Disease Severity: Use of These Variables to Determine Price Benchmarks
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1287
https://www.valueinhealthjournal.com/article/S1098-3015(22)03492-1/fulltext
Title :
HPR158 Progression Free Survival and Duration of Treatment as a Proxy of Disease Severity: Use of These Variables to Determine Price Benchmarks
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03492-1&doi=10.1016/j.jval.2022.09.1287
First page :
Section Title :
Open access? :
No
Section Order :
10838